Biotech bil­lion­aire Hi­roshi ‘Mick­ey’ Mik­i­tani dou­bles down on quest to build a phar­ma com­pa­ny, clos­ing round at $284M

The lat­est bil­lion­aire to be drawn in­to the biotech game is dou­bling down on his Cal­i­for­nia start­up with plans to vault it in­to po­si­tion as a new-wave phar­ma com­pa­ny.

Hi­roshi “Mick­ey” Mik­i­tani has con­tributed to an add-on $134 mil­lion tranche for the C round back­ing Rakuten As­pyr­i­an. That brings the round to $284 mil­lion, much of which came di­rect­ly from the fab­u­lous­ly wealthy Japan­ese e-tail­er.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.